ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
CIP Web Site: http://www.cancer.gov/bip
- American Chemical Society Division Of Nuclear Chemistry And Technology 223rd ACS National Meeting
Orlando, Florida (April 7-11, 2002)
Included in program: Award Symposium: Glenn T. Seaborg Award in Nuclear Chemistry (in Honor of Joanna S. Fowler)
- Society of Nuclear Medicine
June 15, 19, 2002
Los Angeles, California;
NCI Cancer Imaging Program Booth No. 112
- AAPM Workshop on Grantsmanship;
July 19, 2002 (After the AAPM Montreal Meeting);
- The First Annual Meeting of the Society of Molecular Imaging
August 24-26, 2002
- The Academy of Molecular Imaging announces the CALL FOR ABSTRACTS for the 2002 Annual Conference, October 23-27, 2002 at the Sheraton Hotel and Marina, San Diego, California.
Deadline for submission is April 30, 2002
- NIH ANNOUNCES DRAFT STATEMENT ON SHARING RESEARCH DATA (NOT-OD-02-035)
The NIH is developing a statement on data sharing that expects and supports the timely release and sharing of final research data from NIH-supported studies for use by other researchers. Institutions and individuals are invited to comment on the draft policy. Additional information is available online on the NIH web site at: http://grants.nih.gov/grants/policy/data_sharing/index.htm. It is expected that the new policy will be announced on August 1, 2002, with a proposed effective date of January 1, 2003.
- OHRP GUIDANCE
OHRP has updated its November 16, 2001 guidance entitled, "Guidance for Investigators and Institutional Review Boards Regarding Research Involving Human Embryonic Stem Cells, Germ Cells, and Cell-Derived Test Articles." OHRP's March 19, 2002 guidance can be found at
- SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE (SPOREs) IN PANCREATIC CANCER FOR THE YEAR 2002 (NCI) (PAR-02-068)
The Organ Systems Branch of the Office of the Deputy Director for Extramural Science at the National Cancer Institute (NCI) invites grant applications (P50) for Specialized Programs of Research Excellence (SPOREs) in Pancreatic Cancer.
- CHEMOPREVENTION OF ESTROGEN RECEPTOR (ER) NEGATIVE BREAST CANCER PRECLINICAL STUDIES (RFA: CA-03-005)
Letter of intent receipt date: June 27, 2002; application receipt date: July 25, 2002
The initiative will encourage applications focused on 1) validation of surrogate biomarkers, which can be modulated by agents which may prevent Estrogen Receptor (ER) negative breast cancer in animal models of non-hormonally responsive mammary cancer; 2) identification of potential targets found both in hormonally non-responsive animal models of breast cancer and in ER negative breast cancer in humans and 3) determination of the efficacy of potential chemopreventive agents.
- NATIONAL LIBRARY OF MEDICINE POSTDOCTORAL RESEARCH PARTICIPATION PROGRAM
The National Library of Medicine (NLM) Research Participation Programs provide opportunities for members of the academic community (i.e., postgraduates, students, and faculty) to participate in research and development programs, projects, and activities at the world's largest library.
- NEUROSCIENCE RESEARCH ON DRUG ADDICTION (NIDA)(PA-02-085)
The intent of this program announcement is to continue to encourage investigator interest in the wide range of neuroscience research relevant to drug abuse, drug dependence, and drug addiction. Of particular interest are new areas of neuroscience that may be applied to questions of drug abuse and addiction.
- NIDDK MENTORED RESEARCH SCIENTIST DEVELOPMENT AWARD (K01) (PAR-02-065)
The National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) invites applications for Mentored Research Scientist Development Awards (K01) from basic scientists interested in pursuing research careers in the areas of diabetes, endocrinology, metabolic disorders, digestive diseases, etc. The intent of these K01 awards is to provide support for the critical transition period between postdoctoral training and independent R01 funding for those non-clinical investigators whose careers are vital for the future excellence of the NIDDK research endeavor.
- NHLBI MENTORED MINORITY FACULTY DEVELOPMENT AWARD (K01) (RFA-HL-02-022)
The NHLBI Mentored Minority Faculty Development Award is a three to five-year award made to underrepresented minority faculty members, with varying levels of research experience, who are committed to developing into independent biomedical investigators in research areas relevant to the mission of the NHLBI.
- NHLBI SHORT-TERM TRAINING FOR MINORITY STUDENTS PROGRAM (T35) (RFA-HL-02-025)
Letter of intent receipt date: May 20, 2002; application receipt date: June 19, 2002
The National Heart, Lung, and Blood Institute (NHLBI) Short-Term Training for Minority Students Program is a National Research Service Award (NRSA) designed to provide short-term research support to underrepresented minority undergraduate and graduate students and students in health professional schools to provide them with career opportunities in cardiovascular, pulmonary, hematologic and sleep disorders research.
Other Government Agenices
- DEPARTMENT OF DEFENSE BREAST CANCER RESEARCH PROGRAM ANNOUNCEMENT I FOR FISCAL YEAR 2002
Preproposal deadline: April 3, 2002;
Proposal Deadline: August 21, 2002
The Fiscal Year 2002 (FY02) Defense Appropriations Act provides $150 million to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative research directed toward the eradication of breast cancer. This announcement will call for proposals in the following mechanisms: Clinical Translational Research (CTR) Awards, Biotechnology Clinical Partnership Awards, Collaborative-CTR Awards, Breast Cancer Center of Excellence Awards, Historically Black Colleges and Universities/Minority Institutions Partnership Training Awards. Program Announcement I requests proposals through five award mechanisms all requiring a pre-proposal. Pre-proposals must be received by April 3, 2002. New this year: Biotechnology Clinical Partnership Awards are intended to support the establishment of partnerships between the biotechnology industry and academic institutions, and are expected to accelerate the delivery of novel breast cancer therapeutics and chemopreventives.
- DOD FY 02 BREAST CANCER RESEARCH PROGRAM - PROGRAM ANNOUNCEMENT II
Deadlines: June 11-13, 2002
One of the congressional research programs managed by the USAMRMC Office of Congressionally Directed Medical Research Programs (CDMRP) is the Breast Cancer Research Program (BCRP). The overall goal of the BCRP is to promote research directed toward the eradication of breast cancer. In Program Announcement II, the Congressionally Directed Medical Research Programs requests proposals through eight award mechanisms.
- DEPARTMENT OF DEFENSE PROSTATE CANCER RESEARCH PROGRAM (PCRP) FOR FISCAL YEAR 2002 (SRCSGT)
Letter of Intent due: April 30, 2002;
Application deadlines: May 14, 16, 2002 (specific parts)
The Congressionally Directed Medical Research Programs (CDMRP) is requesting proposals on prostate cancer research and training through this program announcement. Proposals will be requested in five previously established PCRP award mechanisms: Idea Development Awards, New Investigator Awards, Postdoctoral Traineeship Awards, Health Disparity Training - Prostate Scholar Awards, and Health Disparity Research - Prostate Scholar Awards. In addition, investigators chosen for funding through the Consortium Development Award in FY01 received supplemental instructions to submit proposals for the Consortium Award in FY02.
- Department of Defense Ovarian Cancer Research Program Announcement for Fiscal Year 2002 (SRCSGT)
Deadline: 6/18/2002 SOL FBP-OCRP-0318
The Fiscal Year 2002 (FY02) Defense Appropriations Act provides $10.2 million to the Department of Defense Ovarian Cancer Research Program (OCRP) to support innovative research directed toward eliminating ovarian cancer. This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP). Proposals are sought in the following four emphasis areas: etiology, prevention, early detection/diagnosis, and preclinical therapeutics. This announcement calls for proposals in the following two new mechanisms: Idea Development Awards and Institutional Training Grants.
- NSF HIGH PERFORMANCE NETWORK CONNECTIONS (HPNC) (NSF-02-073)
Deadline: May 22, 2002
The purpose of this announcement is to encourage additional U.S. institutions of higher education and institutions with significant research and education missions to establish high performance Internet connections (at or above 45mbits per second) where required to facilitate cutting edge science and engineering research.
- OCCUPATIONAL RADIATION AND ENERGY-RELATED HEALTH RESEARCH GRANTS (RFA-OH-02-002)
Letter Of Intent Receipt Date: April 19, 2002;
Application Receipt Date: May 13, 2002
The Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH), announces the availability of fiscal year (FY) 2002 funds for the acceptance of grant applications for research projects relating to occupational safety and health concerns associated with occupational exposures to radiation and other hazardous agents at nuclear facilities and in other energy-related industries.
- RFP FOR MEDICAL IMAGING SYMPOSIUM/WORKSHOP
San Diego, CA, August 10-11, 2003
The proposal must be submitted electronically to the AAPM by May 1, 2002.
The American Association of Physicists in Medicine (AAPM) is soliciting proposals from any individual or group who is interested in developing a 2-day medical imaging research symposium or workshop that would occur Sunday August 10 and Monday August 11, 2003, concurrent with the 2003 AAPM Annual Meeting in San Diego. The symposium should focus on any topic in medical imaging. The successful applicant will be notified by June 15, 2002.
- THE WHITAKER FOUNDATION BIOMEDICAL ENGINEERING RESEARCH GRANTS
Preliminary Applications: April 1, 2002; August 1, 2002; December 1, 2002
Full Applications: June 1, 2002; October 1, 2002; February 1, 2003
The Biomedical Engineering Research Grants program supports research projects that enable investigators to establish academic careers in biomedical engineering or a closely related field. The foundation invites applications from principal investigators (PI's) who hold faculty positions at eligible institutions of higher education. The maximum initial award is $240,000 over three years. This is the final announcement of the Biomedical Engineering Research Grants Program. The Whitaker Foundation operates the following biomedical engineering grant programs: Biomedical Engineering Research Grants, Graduate Fellowships in Biomedical Engineering, Special Opportunity Awards in Biomedical Engineering, Industrial Internships for Biomedical Engineering Students, Teaching Materials Program, and Leadership-Development Awards. The Foundation will spend all its assets and close in 2006. As a result, each of these grant programs are being phased out.
- DAMON RUNYON SCHOLAR AWARD
The Damon Runyon Scholar Award was established to support the development of outstanding scientists as independent investigators in the cancer field by helping foster their research productivity during the first few years of their first faculty position. Five three-year Damon Runyon Scholar Awards at $100,000 are granted to researchers who show exceptional promise of scientific accomplishment and are within the first three years of their assistant professor appointment.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (firstname.lastname@example.org).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507